{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:03:29Z","timestamp":1789898609055,"version":"4.0.1"},"reference-count":11,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T00:00:00Z","timestamp":1250640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Carbamazepine (CBZ) is frequently used for treating epilepsy, but this drug causes cutaneous adverse drug reactions (cADRs) that may range from mild to severe. It is reported recently that the human leukocyte antigen HLA\u2010B*1502 is associated with Stevens\u2010Johnson syndrome (SJS) induced by CBZ in Han Chinese. We examined HLA class I in 15 Japanese patients who fulfilled the diagnostic criteria for CBZ\u2010induced cADRs (mild in 10 and severe\u2003=\u2003SJS in 5). HLA\u2010B*1518, HLA\u2010B*5901 and HLA\u2010C*0704 alleles showed higher relative risks (above 10.0) for severe cADRs. The haplotype (HLA\u2010A*2402\u2010B*5901\u2010C*0102) had high relative risk (16.09) for severe cADRs. In patients with severe cADRs, frequencies of HLA\u2010A*1101, HLA\u2010A*3303, HLA\u2010B*1501, HLA\u2010B*4403, HLA\u2010B*5101, HLA\u2010B*5201, HLA\u2010C*0702, and HLA\u2010C*1202 alleles are relatively lower than in the Japanese population. These data may suggest that HLA\u2010B*5901 is one of the candidate markers for CBZ\u2010induced SJS in Japanese.<\/jats:p>","DOI":"10.1111\/j.1528-1167.2009.02269.x","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T11:43:12Z","timestamp":1250682192000},"page":"297-300","source":"Crossref","is-referenced-by-count":122,"title":["HLA Class I markers in Japanese patients with carbamazepine\u2010induced cutaneous adverse reactions"],"prefix":"10.1111","volume":"51","author":[{"given":"Hiroko","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tateki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahoko","family":"Kaniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,29]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/428486a"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409500102"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000199500.46842.4a"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.11.1617"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2008.00548.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01719.x"},{"key":"e_1_2_6_8_1","volume-title":"The HLA facts book","author":"Marsh SGE","year":"2000"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332404"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1086\/529382"},{"key":"e_1_2_6_11_1","first-page":"33","volume-title":"Report of investigation about diagnosis, treatment and genetic markers in severe cutaneous reaction (H18\u2010002)","author":"Takahashi Y","year":"2007"},{"key":"e_1_2_6_12_1","first-page":"550","article-title":"HLA class I and II gene polymorphisms in Stevens\u2013Johnson syndrome with ocular complications in Japanese","volume":"14","author":"Ueta M","year":"2008","journal-title":"Mol Vis"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1167.2009.02269.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1167.2009.02269.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T15:44:38Z","timestamp":1697384678000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1167.2009.02269.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,29]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1528-1167.2009.02269.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02269.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,29]]}}}